A Story of Hope, Persistence, and an Moving Achievement for Daria, a 5-year-old Girl from Poland Facing a Brain Tumor
📅 On September 3, 2024, we received a touching request from a family in Poland, whose young daughter Daria, age 5, was diagnosed with a
📣 Exciting news! 🎉 Today we secured a new breakthrough drug for a patient we’re accompanying – for FREE! 🆓 Drug cost: 4,864$ per month
🌟 New Discoveries in Colon Cancer Treatment with a New Immunotherapy Combination: What Does the New Study Say? 🌟
📢 Published on June 13, 2024 Researchers from Stanford University have published the results of a study in Nature Medicine that examined the effectiveness of
⭐ Roni: “I feel like my life has been saved in the last hour we’ve been talking, unbelievable.” ⭐
👉Fate can change in an instant. For Roni, 54 years old, a father and husband, that moment came when he reached out to us. Roni
🏥 When Professionalism and Humanity Meet: How We Helped Michal ❤️
We want to share with you the touching story of Michal (a pseudonym), a 32-year-old incredible woman battling metastatic breast cancer, who we have been
🌟 Historia Sukcesu: Walka z Rakiem Przerzutowym z Odwagą i Nadzieją 🌟
Niedawno zwróciła się do nas 30-letnia młoda kobieta z Europy Wschodniej, projektantka tekstyliów z zawodu. Zdiagnozowano u niej wyjątkowo agresywny rak przerzutowy. Onkolog w Niemczech
🌟 **Which is Better for Cancer Patients: Investigational Drugs or Standard Drugs?** 🌟
📢 ** Published on April 30, 2024** Researchers from McGill University in Montreal conducted a comprehensive study involving 128 clinical trials. In this study, there
Colorectal Cancer – Krazati with or without Erbitux in Mutated KRAS G12C
Background Adagrasib, also called “Krazati”, is a tablet taken by mouth which inhibits KRAS G12C mutation. It has shown clinical activity in pretreated patients with
Cannabidiol oil failed to overcome palliative care in advanced cancer
Background The use of cannabis for therapeutic benefit has risen exponentially over the past few years with strong public belief in its benefit. This is
Gastric Cancer – Zolbetuximab Prolongs Survival
About Locally Advanced Unresectable Metastatic Gastric Cancer and Gastroesophageal Junction Cancer (GEJ) Gastric cancer is the fifth most diagnosed cancer worldwide. Signs and symptoms can
Sarcoma – Lenvima Plus Halaven in Advanced Disease
In Short This phase Ib/II study evaluated the efficacy and safety of Lenvima combined with Halaven in the treatment of patients with advanced leiomyosarcoma and
Glioblastoma – Radiotherapy Plus Temodar With Nimotuzumab
Background about Glioblastoma and the new drug Glioblastoma (GBM) has a poor prognosis, and patients with Epidermal Growth Factor Receptor (EGFR) amplification have an even
